03 July 2009
The Federal Trade Commission (FTC) last week issued an interim report that examined the effects of authorized generics on competition in the prescription drug market.
 |
03 July 2009
Although all Member States are in favouring of tightening pharmacovigilance rules, which element of the 'pharma package' is causing dispute?
|
03 July 2009
The Committee for Medicinal Products for Human Use (CHMP) of the EMEA has recommended that the EC grants a marketing authorization for Belgium based-UCB's Cimzia, in combination with methotrexate, for the treatment of rheumatoid arthritis (RA).
|
03 July 2009
Could artificial organs help replace animals experiments? Researchers at the Fraunhofer Institute for Interfacial Engineering and Biotechnology IGB (Germany) believe so; they have developed an artificial liver that they believe will offer greater security for pharma companies and shorten the path to new drugs.
|
03 July 2009
The UK's Medicines and Healthcare Regulatory Agency (MHRA) has published the outcome of a consultation on measures to strengthen the country's medicines supply chain.
|
03 July 2009
Eisai (Japan) has opened its new European Knowledge Centre in Hertfordshire (UK) after investing approximately 117 million euro in the region to help develop new medicines for Alzheimer's Disease, Parkinson's Disease and epilepsy, as well as new treatments for cancer.
|
02 July 2009
The US Pharmacopeial (USP) Convention and the Vietnamese Pharmacopoeia Commission (VPC) have signed a memorandum of understanding (MOU) that will help ensure the safety of Vietnamese medicines.
|
02 July 2009
Better asthma treatments are hoped to arise from a collaboration between Domainex Ltd, St George?s University of London and the University of Manchester (all UK).
|
01 July 2009
Hovione's API plant in Macau (CA, USA), which is responsible for one third of the company's total production, has successfully passed a pre-approval inspection by the FDA.
|
| 
